renal disease – Page 3 – Communicable Diseases Research

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study

남아프리카의 높은 HIV 및 결핵 유병률 환경에서 COVID-19 관련 병원 내 사망률의 위험 요소: 코호트 연구

Article

Published on 2021-09-012022-09-11
Journal: The Lancet. HIV [Category] SARS, 치료제,

A patient with end-stage renal disease who recovered from coronavirus disease 2019 then received a kidney transplant

2019년 코로나바이러스 질병에서 회복된 후 신장 이식을 받은 말기 신장 질환 환자

Case Reports

Published on 2021-08-012022-09-11
Journal: Transplant immunology [Category] Coronavirus, SARS, 치료제,

Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial

입원한 COVID-19 환자의 개선에 대한 재조합 에리트로포이에틴의 효능 및 안전성 평가: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-07-062022-09-10
Journal: Trials [Category] SARS, 임상,

[키워드] 1:1 48 hours Adverse reaction Adverse reactions age approved Arm Bandar Abbas Blinding block randomization blood pressure Care checked chronic lung disease clinical clinical symptom clinical trial clinical trials Committee company comparator Patients composite endpoint control group Controlled clinical trial controls Coronary heart disease COVID-19 COVID-19 patient COVID-19 patients CRP Deep vein Deep vein thrombosis diabetes Diabetes Mellitus Diastolic blood pressure dissemination distilled water Efficacy and safety element End-stage renal disease endogenous enoxaparin erythropoietin ethics committee evaluate evaluate the effect excluded exclusion criteria expected Haemoglobin Health Health care heart disease hospitalised hospitalised COVID-19 patients Hypoxemia immune system infiltration injection intervals Intervention intervention group investigator Iran Laboratory test Laboratory tests LDH Liver disease Local Lung disease lung field lung infiltration lymphocyte Lymphocyte count lymphopenia Medical Science Medical Sciences medication minute number objective oral contraceptive outcome oxygen oxygen partial pressure oxygen saturation parallel-group partial pressure participant Patient PCR performed pharmaceutical Pharmaceutical Company Phase 2 Placebo positive Prevent principal investigator protocol randomised randomised controlled trial Randomized Randomly receive recombinant erythropoietin recruitment Registered registry renal disease reported respiratory respiratory rate Sample size saturation severe COVID-19 symptom severe COVID-19 symptoms Side effect Side effects Standard Standard of care status sterile water Study protocol subcutaneous injection subject supplementary material Systolic blood pressure tachypnea technology the ethics committee thrombosis title Treatment protocol treatment protocols Trial registration university vital signs water water for injection weakened immune system website
[DOI] 10.1186/s13063-021-05363-w PMC 바로가기 [Article Type] Letter

Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial

COVID-19의 장기적인 영향에 대한 아유르베다 중재 및 요가의 안전성 및 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-06-032022-09-10
Journal: Trials [Category] MERS, SARS, 임상,

[키워드] 1:1 Acute coronary syndrome acute respiratory distress acute respiratory distress syndrome Adverse Adverse drug reaction Agastya Agastya Haritaki alcoholism ARDS Arm arrhythmia Ashwagandha Atrial fibrillation Ayurveda baseline biochemical blinded Blinding calculated Care CBC change chronic respiratory disease clinical clinical assessment Clinical Management Protocol comparator completion Computed tomography conducted confidence confidence level coronary syndrome COVID 19 COVID-19 COVID-19 case Critically ill Critically ill patient critically ill patients CTRI D-dimer depressive diabetes Diabetes Mellitus diagnosed Diego disease dropout rate drug drug reaction Effect Efficacy element eligible enrolled enrolment evening excluded exploratory study generate GMP Government Government of India group hematological hepatic disease HIV HRCT hs-CRP hypersensitivity IgM antibodies IgM antibody illness illnesses immunosuppressive medications Impact impaired cognition index India intensive care intensive care unit Intervention invasive respiratory support journal Laboratory parameters lactating women Level life long term long-COVID malignancy management motor neuron motor neuron disease multiple sclerosis Myocardial infarction negative RT-PCR number objective Open-label open-label design outcome parallel group parameter participant Participants past history Patient Pharmaceutical Company Pittsburgh positive RT-PCR Post-COVID pregnant Previous studies protocol provided pulmonary Pulmonary function test pulmonary tuberculosis Quality Quality of life random randomised randomised controlled trial Randomized Randomized controlled trial recruitment Registered registry rehabilitation renal renal disease respiratory Respiratory disease respiratory distress Respiratory function Safety Sample Sample size SARS CoV SARS CoV-2 SARS-CoV-2 scale Science score secondary Secondary outcomes Sex Shortness of breath Sleep sleep quality SPSS Standard deviation status stroke study duration study group study period Study protocol Subjective substance dependence supplementary material syndrome Tablet the study group timeline Trial Trial registration Tuberculosis Version warm water water website WHO yoga
[DOI] 10.1186/s13063-021-05326-1 PMC 바로가기 [Article Type] Letter

Evaluation of the Prognosis of COVID-19 Patients According to the Presence of Underlying Diseases and Drug Treatment

기저질환 유무 및 약물치료에 따른 코로나19 환자의 예후 평가

Article

Published on 2021-05-172022-08-31
Journal: International Journal of Environmental Research an [Category] SARS, 치료제,

[키워드] 95% CI 95% confidence interval ACEi ACEi/ARB Affect analyzed angiotensin angiotensin converting enzyme Angiotensin II ARBs benefit blocker Cancer Chronic kidney disease chronic obstructive chronic obstructive pulmonary disease Comorbidities cooperation coronavirus coronavirus disease COVID-19 COVID-19 cases COVID-19 patients diabete diabetes Diabetic disease disorder drug duration of hospitalization enzyme hazard ratio heart failure higher risk hypertension increased mortality increased the risk inhibitor international cooperation Kidney disease medical treatment Mental Mental disorder Mental Disorders Mortality obstructive pulmonary disease Patient patients patients with COVID-19 PCR tests Presence pulmonary disease receptor Receptor Blockers renal renal disease risk factor RT-PCR test RT-PCR tests severity significantly underlying disease underlying diseases was used
[DOI] 10.3390/ijerph18105342 PMC 바로가기 [Article Type] Article

COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider

미국 투석 환자 중 COVID-19: 국가 투석 제공자의 위험 요인 및 결과

Article

Published on 2021-05-012022-09-11
Journal: American journal of kidney diseases : the official [Category] SARS, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age all-cause mortality Asymptomatic Black race center Characteristics Clinical characteristics clinics cohort study comorbid conditions Comorbidity conducted coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 death defined demographics dialysis dialysis clinic died disease during treatment end-stage kidney disease (ESKD) End-stage renal disease End-stage renal disease (ESRD) Epidemiology ESRD Factor frailty greater heart disease identify initial Kidney disease limit Logistic regression analyses Logistic regression analysis maintenance Male sex marker medications Mortality National nursing home Odds ratio Older age outcome pandemic Patient patients with COVID-19 physical distancing positive rationale receiving renal disease residence retrospective cohort study risk factor Risk factors SARS-CoV-2 SARS-CoV-2 positivity SARS-CoV-2 test selected setting severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Sex symptomatic and asymptomatic test result tested Treatment vulnerable population with COVID-19
[DOI] 10.1053/j.ajkd.2021.01.003 PMC 바로가기 [Article Type] Article

Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom

혈액투석을 받는 말기 신질환 환자에서 COVID-19 항체 검사의 유용성 조사: 영국의 코호트 연구

Research

Published on 2021-04-272022-09-10
Journal: BMC Nephrology [Category] MERS, SARS, 치료기술,

[키워드] addition aims Analysis anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody antibodies Antibody Response Antibody testing approved asymptomatic patient asymptomatic patients baseline characteristics Chain Reaction Characteristics Chi-squared test Chi-squared tests cohort study COVID-19 COVID-19 antibody COVID-19 infection death detectable detectable anti-SARS-CoV-2 antibodies determine diagnosis of COVID-19 disease End-stage renal disease epidemiological ESRD groups Haemodialysis help Hope hospital host immunity humoral Humoral response IgG antibodies improvement increased mortality Infection prevention local outbreaks Mann-Whitney U measure median MONITOR number of deaths Other over Patient patients PCR-positive polymerase chain polymerase chain reaction positive Prevent Prevention and control previous diagnosis proportion provide Real-Time Reverse Transcription Polymerase Chain Reaction receiving recruited renal renal disease Result reverse transcription reverse transcription polymerase chain reaction routine clinical practice rRT-PCR SARS-CoV-2 Serological testing Seroprevalence SKS SPSS statistical analysis supplementary material symptomatic Symptoms tested the antibody response the patient the vaccine the vaccines United Kingdom utility was performed were recorded were used with COVID-19
[DOI] 10.1186/s12882-021-02366-2 PMC 바로가기 [Article Type] Research

Coronavirus disease 2019 (COVID-19) and QTc prolongation

코로나바이러스 질병 2019(COVID-19) 및 QTc 연장

Observational Study

Published on 2021-03-302022-09-01
Journal: BMC Public Health [Category] 임상, 진단,

[키워드] ACEi age angiotensin angiotensin-converting enzyme inhibitor angiotensin-converting enzyme inhibitors arrhythmia Azithromycin baseline cardiac injury cardiovascular disease Chronic kidney disease Combination comparable congestive heart failure contribute coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients develop diagnosis of COVID-19 drug Ejection fraction End-stage renal disease ESRD heart disease hospital Hospitalization Hospitalized Hydroxychloroquine Infection Injury ischemic heart disease Kidney disease less Mortality objective observational study Older Older age Patient preserved prolongation QT prolongation QTc QTc interval QTC prolongation renal disease Result retrospective two groups USA ventricular ventricular arrhythmias virus
[DOI] 10.1186/s12872-021-01963-1 PMC 바로가기 [Article Type] Observational Study

[Recommendations for the management of the patient with chronic renal disease with SARS-CoV-2]

[SARS-CoV-2 만성신질환자 관리를 위한 권고사항]

Case Reports

Published on 2021-02-012022-09-11
Journal: Enferm Clin [Category] SARS, 치료기술,

Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia

중증 코로나19 폐렴을 동반한 일본 ESRD 사례 2건의 성공적인 치료

Case Reports

Published on 2021-02-012022-09-11
Journal: CEN case reports [Category] MERS, SARS, 진단, 치료제,

[키워드] acute respiratory distress acute respiratory distress syndrome acute respiratory distress syndrome (ARDS) Admission anti-cytokine anti-cytokine therapy ARDS Clinical course cohort study coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 pneumonia Diabetic diabetic nephropathy disease distress effective End-stage renal disease End-stage renal disease (ESRD) ESRD exhibited Hemodialysis high mortality rate ICU Immunoglobulin indicate infected with COVID-19 intensive care intensive care unit Intravenous immunoglobulin Intravenous immunoglobulin (IVIG) IVIG Japanese Maintenance hemodialysis mechanical ventilation nephropathy novel Novel coronavirus novel coronavirus disease Patient patients renal renal disease respiratory distress Respiratory distress syndrome Severe COVID-19 pneumonia syndrome Tocilizumab treated Treatment were infected with COVID-19
[DOI] 10.1007/s13730-020-00512-7 PMC 바로가기 [Article Type] Case Reports